Finemedix Co., Ltd. (KOSDAQ:387570)

Finemedix Statistics

Total Valuation

Finemedix has a market cap or net worth of KRW 36.93 billion. The enterprise value is 34.17 billion.

Market Cap	36.93B
Enterprise Value	34.17B

Important Dates

The next estimated earnings date is Thursday, May 14, 2026.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Finemedix has 5.43 million shares outstanding. The number of shares has increased by 12.35% in one year.

Current Share Class	5.43M
Shares Outstanding	5.43M
Shares Change (YoY)	+12.35%
Shares Change (QoQ)	-0.21%
Owned by Insiders (%)	37.29%
Owned by Institutions (%)	n/a
Float	3.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.88
PB Ratio	1.94
P/TBV Ratio	1.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-18.19
EV / Sales	3.59
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.80

Financial Position

The company has a current ratio of 5.30, with a Debt / Equity ratio of 0.21.

Current Ratio	5.30
Quick Ratio	3.58
Debt / Equity	0.21
Debt / EBITDA	n/a
Debt / FCF	-1.13
Interest Coverage	-27.62

Financial Efficiency

Return on equity (ROE) is -9.44% and return on invested capital (ROIC) is -15.97%.

Return on Equity (ROE)	-9.44%
Return on Assets (ROA)	-6.15%
Return on Invested Capital (ROIC)	-15.97%
Return on Capital Employed (ROCE)	-11.31%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.36
Inventory Turnover	1.24

Taxes

Income Tax	-673.85M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.45% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-26.45%
50-Day Moving Average	6,991.60
200-Day Moving Average	7,626.00
Relative Strength Index (RSI)	49.27
Average Volume (20 Days)	9,141

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Finemedix had revenue of KRW 9.52 billion and -1.88 billion in losses. Loss per share was -346.00.

Revenue	9.52B
Gross Profit	4.60B
Operating Income	-2.58B
Pretax Income	-2.55B
Net Income	-1.88B
EBITDA	-1.62B
EBIT	-2.58B
Loss Per Share	-346.00

Balance Sheet

The company has 6.69 billion in cash and 3.93 billion in debt, with a net cash position of 2.76 billion or 508.11 per share.

Cash & Cash Equivalents	6.69B
Total Debt	3.93B
Net Cash	2.76B
Net Cash Per Share	508.11
Equity (Book Value)	19.00B
Book Value Per Share	3,506.93
Working Capital	11.67B

Cash Flow

In the last 12 months, operating cash flow was -2.63 billion and capital expenditures -852.10 million, giving a free cash flow of -3.49 billion.

Operating Cash Flow	-2.63B
Capital Expenditures	-852.10M
Depreciation & Amortization	961.79M
Net Borrowing	296.64M
Free Cash Flow	-3.49B
FCF Per Share	-641.95

Margins

Gross margin is 48.34%, with operating and profit margins of -27.10% and -19.72%.

Gross Margin	48.34%
Operating Margin	-27.10%
Pretax Margin	-26.80%
Profit Margin	-19.72%
EBITDA Margin	-17.00%
EBIT Margin	-27.10%
FCF Margin	n/a

Dividends & Yields

Finemedix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.35%
Shareholder Yield	-12.35%
Earnings Yield	-5.09%
FCF Yield	-9.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Finemedix has an Altman Z-Score of 4.79.

Altman Z-Score	4.79
Piotroski F-Score	n/a